A Phase 1 Bioequivalence Study To Compare The Plasma Pharmacokinetics Of AG-013736 Polymorph Form IV Versus Market-Image Polymorph Form XLI Tablets In Healthy Volunteers Under Fed Conditions.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Axitinib (Primary)
- Indications Breast cancer; Colorectal cancer; Gastric cancer; Gastrointestinal cancer; Non-small cell lung cancer; Renal cancer; Solid tumours; Thyroid cancer
- Focus Pharmacokinetics
- Sponsors Pfizer
- 23 Apr 2010 Actual patient number (42) added as reported by ClinicalTrials.gov.
- 23 Apr 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 23 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.